In collaboration with Payame Noor University and Iranian Society of Physiology and Pharmacology

Document Type : Article

Authors

Department of Biology Shiraz Branch, Islamic Azad University, Shiraz, Iran

Abstract

Abstract
Human studies have great challenges in understanding the pathogenesis of polycystic ovary syndrome due to ethical and practical limitations and animal models have high value in the study of this syndrome. Regarding estrogenic properties of royal jelly, the aim of this study was to investigation of establishment possibility of royal jelly-induced polycystic ovary syndrome disorder model in rat. In this experimental study,40 adult virgin female rats strain weighing 180±20grwere divided in 5 groups of 8. control group without treatment, sham group received normal saline as treatment solvent and 3 experimental groups respectively intraperitoneally injection received 250, 500 and 1000mg/kgBW of royal jelly for 21 days.At the end of the treatment period the blood samples were taken from all groups, serum concentration of sex hormones were measured and the follicles were counted by isolating the ovaries and preparing the tissue sections. The data were analyzed using one-way ANOVA. The results of this study showed that the serum concentration estradiolhormone and the number of primordial follicles in the 250mg/kgBW recipient group were significantly increase than control group (p<0.05); Also ovarian cysts were not observed in histopathologic examination of ovarian tissue. Royal jelly increases serum concentration estradiol hormone and the number of primordial follicles at a minimal dosage but with increasing does not changes in serum concentration of sex hormones also tissue and ovarian function.
 

Keywords

 
References
 
Boots, CE.; Jungheim, ES.; (2015). Inflammation and Human Ovarian Follicular Dynamics. SeminReprod Med; 33(4): 270-275.
Chen, YF.; Wang, K.; Zhang, YZ.; Zheng, YF.; Hu, FL.; (2016). In Vitro Anti-Inflammatory Effects of Three Fatty Acids from Royal Jelly. Mediators Inflamm; 3583684.
Dăneasă, A.; Cucolaş, C.; Lenghel, LM.; Olteanu, D.; Orăsan, R.; Filip, GA.; (2016). Letrozolevs estradiol valerate induced PCOS in rats: glycemic, oxidative and inflammatory status assessment. Reproduction; 151(4): 401-9.
El Hayek, S.; Bitar, L.; Hamdar, LH.; Mirza, FG.; Daoud, G.; (2016). Poly Cystic Ovarian Syndrome: An Updated Overview. Front Physiol.; 7: 124.
Ferreira, D.; Rocha, HC.;  LC Loro, VL.; Marqueze, A.; Koakoski, G.; (2013). Bee Products Prevent Agrichemical-Induced Oxidative Damage in Fish. PLoS ONE; 8(10), e74499.
Garg, D.; Tal, R.; (2016). The role of AMH in the pathophysiology of polycystic ovarian syndrome.Reprod Biomed Online; pii: S1472-6483(16)30070-0.
Ghanbari, E.; Nejati, V.; Khazaei, M.; (2016). Antioxidant and protective effects of Royal jelly on histopathological changes in testis of diabetic rats. Int J Reprod Biomed (Yazd); 14(8): 519-526.
Glintborg, D.; Andersen, M.; (2017). Managementof endocrine disease: Morbidity in polycystic ovary syndrome.Eur J Endocrinol; 176(2): R53-R65.
Hosseini, E.; Frozanfar, M.; Payehdar, A.; (2013). The effect of hydroalcoholic extract of purslane on serum concentration of esterogen, progesterone, prolactin and gonadotropins in mature female rats. J ShahrekordUniv Med Sci; 15(5): 12-21.
Kang, X.; Jia, L.; Shen, X.; (2015). Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model. BioMed Res Int; 2015: 943694.
Kauffman, AS.; Thackray, VG.; Ryan, GE.; Tolson, KP.; Glidewell-Kenney, CA.; Semaan, SJ.; (2015). A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice. BiolReprod; 93(3): 69.
Lee, JA.; Kim, YM.; Hyun, PM.; Jeon, JW.; Park, JK.; Suh, GH.; (2015). Honeybee (Apismellifera) Venom Reinforces Viral Clearance during the Early Stage of Infection with Porcine Reproductive and Respiratory Syndrome Virus through the Up-Regulation of Th1-Specific Immune Responses. Toxins; 7(5): 1837-1853.
Lindheim, L.; Bashir, M.; Münzker, J.; Trummer, C.; Zachhuber, V.;, Leber, B.; (2017). Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study. PLoS ONE; 12(1): e0168390.
Maliqueo, M.; Benrick, A;. Stener-Victorin, E.; (2014). Rodent models of polycystic ovary syndrome: phenotypic presentation, pathophysiology, and the effects of different interventions. SeminReprod Med; 32(3):183-93.
Mohamadi,S.; Deldar, H.; Ansary, Z.; Shoreh, B.; (2016). Effect of royal jelly on gene expression of antioxidant enzymes in in vitro maturation and embryo development of goat oocytes. Animal Production; 18(4): 867-876.
Nahavandi, F.; Nejati, V.; Najafi, G.; (2014). The Effect of Chronic Immobilization Stress and Royal Jelly on Level of Steroid Hormones, Cortisol and Histological Changes in Uterine Tissue in Female Mice. J MazandaranUniv Med Sci; 24(118): 60-70URL: http://jmums.mazums.ac.ir/article-1-4579-fa.html
Nascimento, AP.; Moraes, LAR.; Ferreira, NU.; Moreno, GP.; Uahib, FGM.; Barizon, EA.; Berretta, AA.; (2015). The Lyophilization Process Maintains the Chemical and Biological Characteristics of Royal Jelly. Evid Based Complement Alternat Med; 2015: 825068.
Padmanabhan, V.; Veiga-Lopez, A.; (2013). Animal models of the polycystic ovary syndrome phenotype. Steroids; 78(8): 734-740.
Pasupuleti, VR.; Sammugam, L.; Ramesh, N.; Gan, SH.; (2017). Propoli and Royal Jelly: A Comprehensive Review of Their Biological Actions and Health Benefits. Oxid Med Cell Longev; 2017: 1259510.
Poluzzi, E.; Piccinni, C.; Raschi, E.; Rampa, A.; Recanatini, M.; Ponti, FD.; (2014). Phytoestrogens in Postmenopause: The State of the Art from a Chemical, Pharmacological and Regulatory Perspective. Curr Med Chem.; 21(4): 417-436.
Sørensen, AE.; Wissing, ML.; Englund, ALM.; Dalgaard, LT.; (2016). MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes. J ClinEndocrinolMetab; 101(4): 1579-1589.
Urniawan, E.; Djuwantono, T.; Sabarudin, U.; Krisnadi, SR.; Permadi, W.; Madjid, TH.; (2014). Difference of endometrial thickness and vascularity in women stimulated by clomiphene citrate with and without vitamin C and E. Am J of Research Communication; 2(10): 11-22.
Victor, VM.; Rovira-Llopis, S.; Bañuls, C.; Diaz-Morales, N.; Martinez de Marañon, A.; Rios-Navarro, C.; (2016). Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase. PLoS ONE; 11(3): e0151960.
Walters, KA.;(2016). Androgens in polycystic ovary syndrome: lessons from experimental models. Curr Opin Endocrinol Diabetes Obes; 23(3): 257-263.
Wang, L.; Qi, H.; Baker, P.N.; Zhen, Q.; Zeng, Q.; (2017). Altered Circulating Inflammatory Cytokines Are Associated with Anovulatory Polycystic Ovary Syndrome (PCOS) Women Resistant to Clomiphene Citrate Treatment. Med SciMonit; 23: 1083-1089.
Wocławek-Potocka, I.; Mannelli, C.; Boruszewska, D.; Kowalczyk-Zieba, I.; Waśniewski, T.; Skarżyński, DJ.; (2013). Diverse Effects of Phytoestrogens on the Reproductive Performance: Cow as a Model. Int J Endocrinol; 650984.
Yee, T L.; Victoria, L.; Hiu, Y L.; Yin, W F.;  Sophia, FS.; (2017). Animal models of atherosclerosis.Biomed Rep; 6(3): 259-266.
Zhang, N.; Li, D.; Shao, J.; Wang, X.; (2015). Animal models for bladder cancer: The model establishment and evaluation (Review). OncolLett; 9(4): 1515-1519.